4//SEC Filing
Boston Megan 4
Accession 0001012975-25-000811
CIK 0001808898other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:35 PM ET
Size
5.2 KB
Accession
0001012975-25-000811
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2025-11-18+200,000→ 200,000 totalExercise: $13.53Exp: 2035-11-18→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:35 PM ET
- Size
- 5.2 KB